Colclasure Chris MD is categorized under Ear Nose and Throat Doctors in Little Rock, AR and active since 1972.
Colclasure Chris MD was established in 1972, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Ear Nose and Throat Doctors business, which does work in the B2C market, and is classified as a Ear Nose and Throat Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Chris Colclasure at the company’s single location by writing to 10201 Kanis Road, Little Rock, Arkansas AR 72205 or by phoning (501) 227-5050. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Colclasure Chris MD |
| Contact Person: | Chris Colclasure |
| Address: | 10201 Kanis Road, Little Rock, Arkansas 72205 |
| Phone Number: | (501) 227-5050 |
| Website Address: | araoc.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1972 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Ear Nose and Throat Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Colclasure Chris MD was started in 1972 to provide professional Ear Nose and Throat Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Chris Colclasure for inquiries that concern Colclasure Chris MD by calling the company number (501) 227-5050, as your correspondence is most welcome. Additionally, the physical location of the single location of Colclasure Chris MD can be found at the coordinates 34.74285,-92.38834 as well as the street address 10201 Kanis Road in Little Rock, Arkansas 72205.
For its online presence, you may visit Colclasure Chris MD’s website at araoc.com and engage with its social media outlets through on Twitter and on Facebook.